Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Respiratory guidelines--which real world?
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.
Risk of Procedural Hemorrhage.
Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
Thromboembolic Disease in Patients with Metastatic Femoral Lesions: A Comparison Between Prophylactic Fixation and Fracture Fixation.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (123)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Institution
Department
Faculty Rank
Name
Institution
Why
Mary Qiu
University of Chicago
Why?
Issam Awad
University of Chicago
Why?
Uzma D. Siddiqui
University of Chicago
Why?
Rakesh Navuluri
University of Chicago
Why?
Jonathan M Lorenz
University of Chicago
Why?
Ryan Merkow
University of Chicago
Why?
Charles Medert
University of Chicago
Why?
Septimiu Murgu
University of Chicago
Why?
Melody Swartz
University of Chicago
Why?
Mark Talamonti
University of Chicago
Why?
Jerrold Leikin
University of Chicago
Why?
Timothy Plackett
University of Chicago
Why?
Gregory Zagaja
University of Chicago
Why?
Erhan Akpinar
University of Chicago
Why?
Brian S. Funaki
University of Chicago
Why?
Per Page
15
25
50
100
Page
of 9
Next
Prev
Search Criteria
Drainage
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions